Approximately 50% of Americans will be obese by 2030, and as more adults struggle with excess weight, medical weight loss programs with semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are becoming increasingly popular weight loss solutions
NEAT: the hidden calorie burner Non-exercise activity thermogenesis, or NEAT, refers to all the calories you burn through movement that is not deliberate exercise
The functional ranges for men are 39-45% while for women they are between 37-44%
In some embodiments, a formulation described herein is manufactured as a suspension in a single vial formulation containing the micronized active pharmaceutical ingredient
[3] [4] The Wegovy Summary of Product Characteristics (SmPC) specifically lists 'heart rate increased' as an adverse reaction, although tachycardia (rapid heart rate) is not listed as a common side effect in the Ozempic SmPC
Be cautious of potential interactions with other medications: Anti-diabetic agents, especially insulin and sulfonylureas (e.g., glyburide, glipizide, glimepiride), as they may increase the risk of hypoglycemia (low blood sugar)
